Lindbrook Capital’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-19
Closed -$237 2794
2023
Q1
$237 Buy
+19
New +$364 ﹤0.01% 2710
2022
Q4
Sell
-13
Closed 2912
2022
Q3
$0 Sell
13
-57
-81% -$1.57K ﹤0.01% 2758
2022
Q2
$2K Buy
70
+62
+775% +$1.65K ﹤0.01% 1977
2022
Q1
$0 Hold
8
﹤0.01% 2549
2021
Q4
$0 Sell
8
-117
-94% -$4.25K ﹤0.01% 2141
2021
Q3
$5K Hold
125
﹤0.01% 1240
2021
Q2
$8K Hold
125
﹤0.01% 1134
2021
Q1
$7K Hold
125
﹤0.01% 1151
2020
Q4
$6K Buy
125
+34
+37% +$1.17K ﹤0.01% 1115
2020
Q3
$3K Buy
+91
New +$2.86K ﹤0.01% 1279
2020
Q2
Sell
-19
Closed -$1K 1791
2020
Q1
$1K Buy
+19
New +$913 ﹤0.01% 1476

Other funds holding INGN

Lindbrook Capital's INGN Position: Q2 2023 in Review

Lindbrook Capital sold out of Inogen (INGN) in Q2 2023, closing a stake of 19 shares — an estimated $237 sold.

Lindbrook Capital first reported a position in INGN in Q1 2020 and held it in 11 quarters. The position peaked at $8K in Q2 2021. 139 funds tracked by Wall St. Rank hold INGN as of Q2 2023.

  • Lindbrook Capital reported no remaining Inogen position as of Q2 2023 after selling out during the quarter.
  • Lindbrook Capital sold 19 Inogen shares in Q2 2023, an estimated $237.
  • Lindbrook Capital first reported a position in Inogen in Q1 2020 and held it in 11 quarters.
  • Lindbrook Capital's Inogen position peaked at $8K in Q2 2021.
  • 139 funds tracked by Wall St. Rank held Inogen as of Q2 2023.

Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.